2015 Annual Meeting | 1HC.006 - Current Management of Incidental and Asymptomatic Cerebrovascular Lesions

Date Saturday 04/18/15

Time 08:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Seemant Chaturvedi, MD, FAHA, FAAN

Topic(s)

Learning Objectives Participants should become aware of the most recent clinical trial and population-based data pertaining to asymptomatic neurovascular conditions, such as unruptured aneurysms and AVMs, and asymptomatic carotid stenosis. Participants should also have an appreciation for which treatments are potentially cost-effective.

CME Available 3.75 CME credits

Program Tracks Subspecialty in Focus

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Event Timeline
08:00 AM - 08:10 AM		Introduction Antonio Culebras, MD, FAHA, FAAN
08:10 AM - 08:55 AM		What Is the Latest on Intracranial Arteriovenous Malformations? Hooman Kamel, MD
08:55 AM - 09:40 AM		Current Status of Asymptomatic Carotid Stenosis Treatment Options Seemant Chaturvedi, MD, FAHA, FAAN
09:40 AM - 09:55 AM		Questions and Answers
09:55 AM - 10:10 AM		Break
10:10 AM - 10:55 AM		Unruptured Intracranial Aneurysms: When and How Should We Treat? Italo Linfante, MD
10:55 AM - 11:40 AM		Costs of Imaging and Treating Stroke: Are We Breaking the Bank? James F. Burke, MD
11:40 AM - 12:00 PM		Questions and Answers

Faculty Disclosures
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
James F. Burke, MD	Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH.
Antonio Culebras, MD, FAHA, FAAN	Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received publishing royalties from a publication relating to health care. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a RESEARCH REVIEWER with DEPARTMENT OF DEFENSE. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a REVIEWER with DOD.
Italo Linfante, MD	Dr. Linfante has received personal compensation for serving as an employee of medtronic. Dr. Linfante has received personal compensation for serving as an employee of stryker. Dr. Linfante has received personal compensation for serving as an employee of cerenovus. Dr. Linfante has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for medtronic. Dr. Linfante has received stock or an ownership interest from InNeuroCO. Dr. Linfante has received stock or an ownership interest from Stryker/Surpass.

��ɫ��

��ɫ��